• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.

作者信息

Tarakhovsky A, Zaichuk T, Prassolov V, Butenko Z A

机构信息

Department of Leukemiagenesis, Academy of Sciences Ukrainian SSR, Kiev.

出版信息

Oncogene. 1991 Dec;6(12):2187-96.

PMID:1685016
Abstract

Medium conditioned by mouse peritoneal macrophages, activated by muramyl dipeptide (MDP), was used as a possible source of p185neu-specific ligand. MDP-activated macrophage-conditioned medium (MDP-CM) was shown to induce p185neu down-regulation in NEU-expressing NIH3T3 cells in a dose-dependent and temperature-sensitive manner. To exclude the possibility of an indirect action of proteins/metabolites present in MDP-CM on p185neu turnover, a ligand-trapping approach was used. Secreted NEU protein possessing only the extracellular domain but lacking transmembrane and protein kinase domains was expressed in HeLa cells and then purified from conditioned medium, using affinity chromatography on WGA-Sepharose. Co-incubation of the truncated, soluble NEU protein preparation with MDP-CM abolished MDP-CM-induced p185neu down-regulation and reduced self-phosphorylation. It is concluded that a putative p185neu-specific ligand is produced by macrophages activated by MDP. Using MDP-CM, the presence of a 25 kDa polypeptide distinct from EGF, PDGF, FGF, IGF, TGF-alpha and TGF-beta and TNF-alpha, could be demonstrated by decorating a Western blot with soluble NEU and anti-NEU antibodies. Thus, a 25 kDa (non-reduced) p185neu ligand has been described.

摘要

相似文献

1
A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
Oncogene. 1991 Dec;6(12):2187-96.
2
Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.胞壁酰二肽或脂多糖对豚鼠腹腔渗出巨噬细胞中Fc受体表达的下调作用
J Immunol. 1985 Jun;134(6):3705-11.
3
The role of the neu oncogene product in cell transformation and normal development.神经癌基因产物在细胞转化和正常发育中的作用。
Princess Takamatsu Symp. 1988;19:45-57.
4
Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.新糖蛋白偶联的胞壁酰二肽对杜氏利什曼原虫感染的保护作用:细胞因子的作用
J Immunol. 1997 Jun 1;158(11):5357-65.
5
Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*.p185neu*跨膜结构域对血小板衍生生长因子β受体的致癌激活作用。
Oncogene. 1998 Feb 19;16(7):843-51. doi: 10.1038/sj.onc.1201590.
6
Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.雪旺细胞在周围神经发育和华勒氏变性过程中neu原癌基因的表达。
J Neurosci Res. 1992 Apr;31(4):622-34. doi: 10.1002/jnr.490310406.
7
Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.组成型激活的neu癌蛋白酪氨酸激酶干扰生长因子诱导的基因激活信号。
J Cell Biochem. 1991 Jan;45(1):69-81. doi: 10.1002/jcb.240450114.
8
Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.酪氨酸激酶活性与p185neu癌蛋白转化能力的关联。
Oncogene. 1989 Oct;4(10):1175-83.
9
Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.通过共表达截短的neu蛋白抑制p185neu激酶活性和细胞转化。
Oncogene. 1996 Nov 21;13(10):2149-57.
10
Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
Oncogene. 1989 Jan;4(1):81-8.

引用本文的文献

1
Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.层粘连蛋白激活p185HER2癌蛋白并介导乳腺癌细胞的生长抑制。
Br J Cancer. 1996 Nov;74(9):1427-33. doi: 10.1038/bjc.1996.560.
2
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.ErbB-2是神经分化因子(NDF)和表皮生长因子(EGF)受体的常见辅助亚基:对乳腺癌的影响。
EMBO J. 1996 Jan 15;15(2):254-64.
3
Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha.肿瘤坏死因子α对人ERBB2和表皮生长因子受体的反向调节
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8972-6. doi: 10.1073/pnas.90.19.8972.
4
Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency.在人肺腺癌细胞系Calu-3中,抗体诱导的p185HER2激活需要双价性。
Cancer Immunol Immunother. 1993 Jun;36(6):397-402. doi: 10.1007/BF01742256.
5
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.神经分化因子(NDF/heregulin)与Neu/HER-2的细胞类型特异性相互作用表明存在复杂的配体-受体关系。
EMBO J. 1993 Mar;12(3):961-71. doi: 10.1002/j.1460-2075.1993.tb05737.x.
6
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.表皮生长因子相关肽在人类乳腺癌发病机制中的作用
Breast Cancer Res Treat. 1994 Jan;29(1):11-27. doi: 10.1007/BF00666178.
7
Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
Breast Cancer Res Treat. 1994;31(2-3):175-82. doi: 10.1007/BF00666151.
8
The neu-protein and breast cancer.神经蛋白与乳腺癌
Virchows Arch. 1995;426(2):107-15. doi: 10.1007/BF00192631.